Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence

2020/01/20 by Wiebke Pruessmann, W. Pruessmann, Julie Rytlewski +18 · 1 citation
Immunology and Microbiology · Medicine · #CAR-T cell therapy research #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses

paper · doi:10.1038/s43018-019-0019-5

crossref issued 2020/01/20 · crossref published 2020/01/20 · crossref published-online 2020/01/20 · openalex publication_date 2020/01/20 · crossref created 2020/01/20 · crossref deposited 2022/12/07 · openalex created_date 2025/10/10 · crossref indexed 2026/05/12 · openalex updated_date 2026/08/01

Citations

• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
• A working guide to boosted regression trees
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
• Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Cited by

• Thomas S. Kupper [wikipedia]